You can buy shares of Healthpeak Properties and Pfizer with well less than $100 at the moment. At the moment, anyone with ...

We said it was undervalued, and it delivered. Back then, it traded at a P/E below 5. Now it’s rerated to 9.03. Despite the rally, we think it hasn’t outrun its fundamentals. Earnings are solid, and ...

Key Points The chip industry is booming thanks to AI.Advanced Micro Devices is seeing margins and earnings soar as its data ...

LFGY blends crypto and tech exposure with an option-income strategy, offering high yield but lower returns and less ...

These four Dividend Aristocrats are in the penalty box after a very weak showing in the first half of 2025 but are priced ...

Novo shares are a bargain, trading at 18 times earnings estimates. The catch is it's a wobbly time to invest – in May, the ...

Medtronic is a medical device powerhouse closing in on Dividend King status. Merck is a high-yield pharmaceutical giant with ...

Dear Dave, I’m just starting to dip my toe into investing, and I was wondering what you think about bonds. I would appreciate ...

That said, there has been a shocking rise in the price of cocoa, a key input in making chocolate. That will lead to a mid-30% ...

Before diving in, let's trace Nvidia's path to $4 trillion. Nvidia has seen its market capitalization surge in a short period ...

Key Points The airline industry has undergone significant changes, and Delta Air Lines is at the forefront of achieving ...

My strategy prioritizes high earnings yield and dividend yield, aiming for stocks with reliable payouts and low valuations.